20. KAPA GLOBIN DEPLETION HYBRIDIZATION OLIGOS - INVIMA Registration 06b7f11ec1cd331ff13fc53db8b1f4c4
Access comprehensive regulatory information for 20. KAPA GLOBIN DEPLETION HYBRIDIZATION OLIGOS (20. KAPA GLOBIN DEPLETION HYBRIDIZATION OLIGOS) in the Colombia medical device market through Pure Global AI's free database. This I medical device is registered under INVIMA analysis ID 06b7f11ec1cd331ff13fc53db8b1f4c4 and manufactured by ROCHE SEQUENCING SOLUTIONS, INC. The device was registered on February 09, 2033.
This page provides complete registration details including product type (REACTIVOS IN VITRO), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
LOS REACTIVOS RUO AMPARADOS EN ES ESTE REGISTRO SANITARIO SON REACTIVOS PARA LA PREPARACION DE MUESTRAS, AMPLIFICACION_x000D_ DETECCIÒN Y/O CUANTIFICACIÓN EN MUESTRAS BIOLOGICAS DE ORIGEN HUMANO, DE LOS ACIDOS NUCLÉICOS DNA/RNA. SU PLATAFORMA_x000D_ TECNOLÓGICA ES POR TECNICAS DE BIOLOGIA MOLECULAR POR AMPLIFICACIÓN EN CADENA DE POLIMERASA PCR.
THE RUO REAGENTS COVERED IN THIS SANITARY REGISTRY ARE REAGENTS FOR THE PREPARATION OF SAMPLES, AMPLIFICACION_x000D_ DETECTION AND / OR QUANTIFICATION IN BIOLOGICAL SAMPLES OF HUMAN ORIGIN, OF NUCLEIC ACIDS DNA / RNA. YOUR PLATAFORMA_x000D_ TECHNOLOGICAL IS BY MOLECULAR BIOLOGY TECHNIQUES BY PCR POLYMERASE CHAIN AMPLIFICATION.